Atria Wealth Solutions, Inc. Teva Pharmaceutical Industries LTD Transaction History

Atria Wealth Solutions, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$10.67 - $14.43 $138 - $187	13 Added 0.08%	16,796 $236,000
Q4 2023 Feb 02, 2024	SELL	$8.12 - $10.63 $8,119 - $10,630	-1,000 Reduced 5.62%	16,783 $175,000
Q2 2023 Aug 03, 2023	SELL	$7.2 - $9.47 $878 - $1,155	-122 Reduced 0.68%	17,783 $133,000
Q1 2023 Aug 22, 2023	BUY	$8.36 - $11.37 $802 - $1,091	96 Added 0.54%	17,879 $158,000
Q1 2023 Jun 14, 2023	BUY	$8.36 - $11.37 $217 - $295	26 Added 0.15%	17,905 $158,000
Q1 2023 May 10, 2023	SELL	$8.36 - $11.37 $217 - $295	-26 Reduced 0.15%	17,879 $158,000
Q4 2022 Aug 30, 2023	BUY	$7.95 - $9.48 $969 - $1,156	122 Added 0.69%	17,905 $163,000
Q4 2022 Feb 13, 2023	SELL	$7.95 - $9.48 $86,289 - $102,895	-10,854 Reduced 37.74%	17,905 $163,000
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $197,286 - $343,670	28,759 New	28,759 $232,000
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $222,678 - $285,258	30,379 New	30,379 $285,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.